Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Oct;81(20):6354-7.
doi: 10.1073/pnas.81.20.6354.

Human apolipoprotein C-II: complete nucleic acid sequence of preapolipoprotein C-II

Human apolipoprotein C-II: complete nucleic acid sequence of preapolipoprotein C-II

S S Fojo et al. Proc Natl Acad Sci U S A. 1984 Oct.

Abstract

Apolipoprotein (apo) C-II is a cofactor for lipoprotein lipase, the enzyme that catalyzes the hydrolysis of triglycerides on plasma triglyceride-rich lipoproteins. The complete coding sequence of apoC-II mRNA has been determined from an apoC-II clone isolated from a human liver cDNA library. A 17-base-long synthetic oligonucleotide based on amino acid residues 5-10 of apoC-II was utilized as a hybridization probe to select recombinant plasmids containing the apoC-II sequence. Two thousand four hundred clones were screened and one apoC-II cDNA clone containing 500 bases was identified. DNA sequence analysis of this clone revealed a 101 amino acid C-II apolipoprotein containing a 22 amino acid signal peptide attached to the amino terminus of the 79 amino acid residue plasma apoC-II. The amino acid sequence of apoC-II determined by nucleic acid analysis is in agreement with the recently determined sequence of plasma apoC-II isolated from normal subjects. The determination of the complete cDNA sequence of apoC-II and the availability of a cDNA probe of apoC-II will facilitate our analysis of the biosynthesis and processing as well as the genomic organization of apoC-II in normal subjects and patients with dyslipoproteinemias characterized by hypertriglyceridemia.

PubMed Disclaimer

References

    1. Biochem Biophys Res Commun. 1970 Oct 9;41(1):57-62 - PubMed
    1. Circ Res. 1970 Oct;27(4):595-600 - PubMed
    1. Biochim Biophys Acta. 1973 Dec 20;326(3):361-77 - PubMed
    1. Biochemistry. 1973 Dec 4;12(25):5050-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3961-5 - PubMed

LinkOut - more resources